{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:57:16Z","timestamp":1698659836668},"reference-count":31,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1680,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1111\/j.1600-0560.2010.01663.x","type":"journal-article","created":{"date-parts":[[2011,1,25]],"date-time":"2011-01-25T07:41:26Z","timestamp":1295941286000},"page":"443-447","source":"Crossref","is-referenced-by-count":10,"title":["Cutaneous Hodgkin-type lymphoproliferative lesion associated with immunomodulatory therapy for ulcerative colitis"],"prefix":"10.1111","volume":"38","author":[{"given":"Bego\u00f1a","family":"Vieites","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainiero","family":"Avila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Biscuola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Carvajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,25]]},"reference":[{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/ijc.24741","article-title":"Cancer and viral infections in immunocompromised individuals.","volume":"125","author":"Schulz","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.sder.2006.12.002","article-title":"Complications and adverse reactions in the use of newer biologic agents.","volume":"26","author":"Callen","year":"2007","journal-title":"Semin Cutan Med Surg"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/ibd.20797","article-title":"Therapeutic strategies for the management of ulcerative colitis.","volume":"15","author":"Ng","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis.","volume":"35","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.critrevonc.2004.11.010","article-title":"Cancer incidence after immunosuppressive treatment following kidney transplantation.","volume":"56","author":"Andr\u00e9s","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaad.2005.10.015","article-title":"Primary cutaneous T-cell lymphoma occurring after organ transplantation.","volume":"54","author":"Ravat","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00000478-199610000-00015","article-title":"Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy.","volume":"20","author":"Kamel","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00000478-200604000-00007","article-title":"Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically.","volume":"30","author":"Pitman","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB9|cit9","first-page":"336","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Van Krieken","year":"2008"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswold's meeting.","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2007.07682.x","article-title":"Cutaneous side-effects in patients with rheumatic diseases during application of tumor necrosis factor-\u03b1 antagonists.","volume":"156","author":"Lee","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00063030-200014050-00004","article-title":"Skin cancer risk associated with immunosuppressive therapy in organ transplant recipients: epidemiology and proposed mechanisms.","volume":"14","author":"Kuijken","year":"2000","journal-title":"BioDrugs"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jaad.2004.03.047","article-title":"Aggressive cutaneous T-cell lymphomas after TNF\u03b1 blockade.","volume":"51","author":"Adams","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000069965","article-title":"Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy.","volume":"206","author":"Devos","year":"2001","journal-title":"Dermatology"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB15|cit15","first-page":"1","article-title":"Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors.","volume":"4","author":"Exarchou","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB16|cit16","unstructured":"Borisch B Raphael M Swerdlow SH et al. Immunodeficiency associated lymphoproliferative disorders. Jaffe ES Lee Harris N Stein H Vardiman JW WHO classification of tumours of haematopoietic and lymphoid tissues International Agency for Research on Cancer Press 2001 257"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB17|cit17","first-page":"350","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Gaulard","year":"2008"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archderm.133.7.867","article-title":"Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis.","volume":"133","author":"Paul","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/art.22579","article-title":"The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.","volume":"56","author":"Wolfe","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/modpathol.2009.131","article-title":"Immunomodulator agent-related lymphoproliferative disorders.","volume":"22","author":"Hasserjian","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1080\/10428190801911662","article-title":"Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients.","volume":"49","author":"Pietersman","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/00000478-199606000-00014","article-title":"Primary cutaneous Hodgkin's disease with evolution to systemic disease: association with the Epstein-Barr virus.","volume":"20","author":"Kumar","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-0560.1995.tb00743.x","article-title":"Cutaneous Hodgkin's disease: an immunohistochemical analysis.","volume":"22","author":"Cerroni","year":"1995","journal-title":"J Cutan Pathol"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00000372-199804000-00022","article-title":"Skin as the primary site of Hodgkin's disease: a case report of primary cutaneous Hodgkin's disease and review of its relationship with non-Hodgkin's lymphoma","volume":"20","author":"Guitart","year":"1998","journal-title":"Am J Dermatopathol"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/9780470987445.ch17","volume-title":"An illustrated guide of skin lymphoma","author":"Cerroni","year":"2004"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.0303-6987.2005.00280.x","article-title":"Indolent course of the cutaneous Hodgkin's disease.","volume":"32","author":"Jurisic","year":"2005","journal-title":"J Cutan Pathol"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00000372-199402000-00002","article-title":"Primary cutaneous Hodgkin disease: unique clinical, morphologic and immunophenotypic findings.","volume":"16","author":"Sioutos","year":"1994","journal-title":"Am J Dermatopathol"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB29|cit29","first-page":"207","volume-title":"WHO classification of tumours. Pathology and genetics of skin tumours","author":"Jaffe","year":"2006"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB30|cit30","first-page":"326","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Stein","year":"2008"},{"key":"10.1111\/j.1600-0560.2010.01663.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2559.2009.03462.x","article-title":"BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphoma.","volume":"56","author":"Hoeller","year":"2010","journal-title":"Histopathology"}],"container-title":["Journal of Cutaneous Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0560.2010.01663.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0560.2010.01663.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T07:48:17Z","timestamp":1625644097000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0560.2010.01663.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,25]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0560.2010.01663.x","relation":{},"ISSN":["0303-6987"],"issn-type":[{"value":"0303-6987","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,25]]}}}